This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Efficacy and comparative risk of side effects

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • no more effective than existing NSAIDs e.g. ibuprofen

  • no convincing evidence that the risk of severest GI side effects (e.g. development of peptic ulcer disease, GI bleeding, peptic ulcer perforation) is lower with meloxicam than other NSAIDs

  • there is evidence that when meloxicam is used in the lower dose of 7.5 mg daily it appears less likely than some NSAID formulations to cause nausea, dyspepsia, abdominal pain and diarrhoea; when used at the higher dose of 15 mg daily the risk of unwanted effects increases (1)

Reference:

  • (1) Drug and Therapeutics Bulletin (1998), 36 (8), 62-4.

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.